India this week published the draft of a Green Credit Programme aimed at incentivising environmentally conscious practices to promote a sustainable lifestyle as part of the broader Indian initiative, Lifestyle for Environment (LiFE).  The new Green Credit Programme aims to lay the foundation for a market-based mechanism to promote “a grassroot mass movement for combating […] Continue reading ->
A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading ->
Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms.  “How symptomatic a person […] Continue reading ->
The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries.  Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading ->
Peru is experiencing its worst-ever outbreak of dengue fever, with over 172,000 cases by Monday, according to the country’s health department. Of these, over 92,000 are confirmed while almost 80,000 are suspected cases, with countrywide floods and increasing temperatures driving the outbreak. The country has declared a health emergency in 222 districts. The north-western provinces […] Continue reading ->